Clinical Trials | November 03, 2022
SRL Diagnostics inaugurates an upgraded laboratory at Gurugram
The laboratory is equipped to perform high-volume diagnostic testing services
The laboratory is equipped to perform high-volume diagnostic testing services
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
Approval based on HIMALAYA Phase III trial results which showed single priming dose of Imjudo added to Imfinzi reduced risk of death by 22% vs. sorafenib
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Subscribe To Our Newsletter & Stay Updated
